At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Angiogenesis Inhibitors and Hypertension: Clinical Aspects
In Brief
An observational study for Hypertension. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The aim of the study is to find simple clinical and laboratory parameters to predict the development of hypertension and to elucidate the mechanism of hypertension during treatment with the tyrosine kinase inhibitor Sunitinib.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesNetherlands
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
First PostedAug 2007
Study CompletionDec 2009
TodayJul 2026
First PostedAug 6, 2007
Enrollment StartAug 1, 2007
Study CompletionDec 1, 2009
TodayJul 2, 2026
Posted 18.9 years ago